Repurposing in 2020: Teaching Old Drugs New Tricks

A ONE-SHOT cure for vasoplegic syndrome remains elusive to modern medicine. However, the search for agents (new and old) to succor patients in times of hypotension and resultant end-organ failure continues to endure. This is likely because of the extreme exasperation felt by clinicians who witness the rapid decline in patients who cannot maintain that magical mean arterial pressure of 60 mmHg. Two agents that were developed for quite different purposes other than the treatment of refractory vasoplegic shock were examined by Furnish et al.
Source: Journal of Cardiothoracic and Vascular Anesthesia - Category: Anesthesiology Authors: Tags: Editorial Source Type: research